Drug Shortage Report for TEVA-MOMETASONE
| Report ID | 155149 |
| Drug Identification Number | 02248130 |
| Brand name | TEVA-MOMETASONE |
| Common or Proper name | MOMETASONE 0.1% OINT |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 0.1% |
| Dosage form(s) | OINTMENT |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 15 |
| ATC code | D07AC |
| ATC description | CORTICOSTEROIDS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-02-15 |
| Estimated end date | 2022-04-20 |
| Actual end date | 2022-04-20 |
| Shortage status | Resolved |
| Updated date | 2022-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-04-21 | French | Compare |
| v5 | 2022-04-21 | English | Compare |
| v4 | 2022-03-24 | French | Compare |
| v3 | 2022-03-24 | English | Compare |
| v2 | 2022-02-17 | French | Compare |
| v1 | 2022-02-17 | English | Compare |
Showing 1 to 6 of 6